Key terms

About SAGE

SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain. Its products include ZURZUVAE and ZULRESSO. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest SAGE news

Yesterday 7:10am ET Analysts Offer Insights on Healthcare Companies: SAGE Therapeutics (SAGE), Poseida Therapeutics (PSTX) and Align Tech (ALGN) by TipRanks Yesterday 5:25am ET SAGE Therapeutics: Hold Rating Reiterated Amid Clinical Trial Setbacks and Uncertainties by TipRanks Apr 17 11:30am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE) and Palisade Bio (PALI) by TipRanks Apr 17 11:18am ET H.C. Wainwright concerned over Sage’s next readouts after SAGE-718 miss by TipRanks Apr 17 11:08am ET RBC ‘not altogether surprised’ by Sage move lower after failure in PD by TipRanks Apr 17 9:37am ET Sage Therapeutics cut to Underperform at BofA after Parkinson’s trial fails by TipRanks Apr 17 9:34am ET Sage Therapeutics downgraded to Underperform from Neutral at BofA by TipRanks Apr 17 8:03am ET Sage Therapeutics down 19% at $12.60 after announcing dalzanemdor Phase 2 data by TipRanks Apr 17 6:52am ET SAGE Therapeutics’ Promising Parkinson’s Treatment Results by TipRanks Apr 17 6:34am ET Sage announces Phase 2 study of dalzanemdor did not meet primary endpoint by TipRanks Apr 09 6:40am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE), Apellis Pharmaceuticals (APLS) and ACADIA Pharmaceuticals (ACAD) by TipRanks Mar 28 4:55am ET Sage Therapeutics management to meet with Piper Sandler by TipRanks Mar 27 9:50pm ET Analysts Are Neutral on These Healthcare Stocks: SAGE Therapeutics (SAGE), Adverum Biotechnologies (ADVM) by TipRanks Mar 26 8:42am ET SAGE Therapeutics Board Member Announces Retirement by TipRanks Mar 26 6:12am ET Analysts Are Bullish on These Healthcare Stocks: Apogee Therapeutics, Inc. (APGE), SAGE Therapeutics (SAGE) by TipRanks Mar 11 6:50am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Janux Therapeutics Inc (JANX) and SAGE Therapeutics (SAGE) by TipRanks Feb 23 11:55am ET JPMorgan biotech analysts to hold an analyst/industry conference call by TipRanks Feb 23 11:00am ET JPMorgan biotech analysts to hold an analyst/industry conference call by TipRanks Feb 19 12:51am ET Analysts Conflicted on These Healthcare Names: Gilead Sciences (GILD), SAGE Therapeutics (SAGE) and IQVIA Holdings (IQV) by TipRanks Feb 16 11:22am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 16 8:30am ET Analysts Offer Insights on Healthcare Companies: SAGE Therapeutics (SAGE) and EyePoint Pharmaceuticals (EYPT) by TipRanks Feb 15 10:05am ET SAGE Therapeutics’ Zurzuvae Launch: A Promising Start Amid Operational Cautions by TipRanks Feb 15 10:01am ET Sage Therapeutics price target raised to $28 from $25 at H.C. Wainwright by TipRanks Feb 15 8:56am ET Sage Therapeutics price target raised to $26 from $21 at RBC Capital by TipRanks Feb 15 8:38am ET Sage Therapeutics price target raised to $25 from $23 at Oppenheimer by TipRanks Feb 15 8:03am ET Analysts Conflicted on These Healthcare Names: Genmab (GMAB), cbdMD (YCBD) and SAGE Therapeutics (SAGE) by TipRanks Feb 15 7:20am ET Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF), SAGE Therapeutics (SAGE) and Illumina (ILMN) by TipRanks Feb 15 7:02am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Stryker (SYK), SAGE Therapeutics (SAGE) and Healthcare Services (HCSG) by TipRanks Feb 15 6:11am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Tenet Healthcare (THC), SAGE Therapeutics (SAGE) and American Well (AMWL) by TipRanks Feb 15 1:02am ET Bad News for SAGE Therapeutics, Inc. (US) Stock: This New Risk Has Been Added by TipRanks Feb 14 7:25pm ET Buy Rating for SAGE Therapeutics Amid Strong Early Demand for Zurzuvae and Solid Financial Position by TipRanks

No recent press releases are available for SAGE

SAGE Financials

1-year income & revenue

Key terms

SAGE Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

SAGE Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming